Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H20O10 |
| Molecular Weight | 408.3561 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2C(=O)C=C(CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC2=CC4=C1C=CO4
InChI
InChIKey=SJRACCTZSAUMGO-WIMVFMHDSA-N
InChI=1S/C19H20O10/c1-25-18-9-2-3-26-11(9)5-12-14(18)10(21)4-8(28-12)7-27-19-17(24)16(23)15(22)13(6-20)29-19/h2-5,13,15-17,19-20,22-24H,6-7H2,1H3/t13-,15-,16+,17-,19-/m1/s1
| Molecular Formula | C19H20O10 |
| Molecular Weight | 408.3561 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25111086Curator's Comment: description was created based on several sources, including DOI: 10.1002/aoc.151, p 339, Retrived from https://books.google.es/books?id=vVCGAwAAQBAJ&pg=PA339&lpg=PA339&dq=angina+pectoris+khellol+glucoside&source=bl&ots=4XAYnaL5Bb&sig=12nesrI70kvyvT4dPdGlhXvoZJ4&hl=ru&sa=X&ved=0ahUKEwicjLjsjbPQAhVo6IMKHV6aBMgQ6AEILDAD#v=onepage&q=angina%20pectoris%20khellol%20glucoside&f=false
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25111086
Curator's Comment: description was created based on several sources, including DOI: 10.1002/aoc.151, p 339, Retrived from https://books.google.es/books?id=vVCGAwAAQBAJ&pg=PA339&lpg=PA339&dq=angina+pectoris+khellol+glucoside&source=bl&ots=4XAYnaL5Bb&sig=12nesrI70kvyvT4dPdGlhXvoZJ4&hl=ru&sa=X&ved=0ahUKEwicjLjsjbPQAhVo6IMKHV6aBMgQ6AEILDAD#v=onepage&q=angina%20pectoris%20khellol%20glucoside&f=false
Khelloside is a component of Ammi visnaga L. fruits extract, a medicine which is used in Egypt as remedy for the treatment of kidney stones. Khelloside itself exhibits a wide variety of biological activities including anti-anginal,
antiatherosclerotic, lipid altering, antipyretic and spasmolytic. It was clinically tested for asthma, angina pectoris and skin disease, however its develoment seems to be discontinued.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3865654
Curator's Comment: Studies on monkeys.
The oral dose of 20 mg/kg was given once daily.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:47:58 GMT 2025
by
admin
on
Mon Mar 31 17:47:58 GMT 2025
|
| Record UNII |
ZX4FRZ5WJP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C83858
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
DTXSID40878402
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
441966
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
m254
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
17226-75-4
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
C047312
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
191
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
ZX4FRZ5WJP
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
SUB08381MIG
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107506
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
241-263-3
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
82907
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY | |||
|
100000083099
Created by
admin on Mon Mar 31 17:47:58 GMT 2025 , Edited by admin on Mon Mar 31 17:47:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |